Lyell Immunopharma, Inc. (LYEL)

23.17 -0.93 (-3.86%) USD  |  NASDAQ  |  Mar 03, 14:47
More

Lyell Immunopharma Repurchase of Capital Stock (Quarterly)

Repurchase of Capital Stock (Quarterly) Chart

View Repurchase of Capital Stock (Quarterly) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Repurchase of Capital Stock (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Repurchase of Capital Stock (Quarterly) Range, Past 5 Years

View Repurchase of Capital Stock (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Repurchase of Capital Stock (Quarterly) Benchmarks

View Repurchase of Capital Stock (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade